MedTrace Logo

Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation

NCT02741349 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 825

Last updated 2025-05-16

No results posted yet for this study

Summary

The aim of the present prospective study is to further develop and validate a composite risk score predicting both ischemic and bleeding risk, based on epidemiologic, clinical, biological, and/or morphologic complementary data. First, the investigators will assess the predictive performance of current clinical risk scores. Second, the investigators will assess the potential predictive value of additional markers. Third, the investigators will aim to develop a new risk score.

Conditions

Sponsors & Collaborators

  • Saint Antoine University Hospital

    lead OTHER

Principal Investigators

  • Ariel Cohen, Md, PhD · AP-HP, Hôpital Saint-Antoine, Service de cardiologie, 75012 Paris, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-27
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02741349 on ClinicalTrials.gov